Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis
Clinical trial NCT04413942 · UNKNOWN
Trial details
- NCT number
- NCT04413942
- Sponsor
- Oneness Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-10
- Primary completion
- 2021-12-31
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.